SeaCrest Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,396
| Closed | -$615K | – | 657 |
|
|
2023
Q2 | $615K | Sell |
7,396
-3,168
| -30% | -$264K | 0.08% | 270 |
|
|
2023
Q1 | $805K | Buy |
10,564
+273
| +3% | +$20.8K | 0.11% | 209 |
|
|
2022
Q4 | $854K | Buy |
+10,291
| New | +$854K | 0.12% | 191 |
|
|
2022
Q3 | – | Sell |
-1,283
| Closed | -$95K | – | 1546 |
|
|
2022
Q2 | $95K | Buy |
+1,283
| New | +$95K | 0.01% | 883 |
|
|
2021
Q4 | – | Sell |
-1,778
| Closed | -$224K | – | 735 |
|
|
2021
Q3 | $224K | Buy |
1,778
+100
| +6% | +$12.6K | 0.03% | 591 |
|
|
2021
Q2 | $227K | Sell |
1,678
-100
| -6% | -$13.5K | 0.03% | 605 |
|
|
2021
Q1 | $241K | Hold |
1,778
| – | – | 0.03% | 537 |
|
|
2020
Q4 | $250K | Buy |
+1,778
| New | +$250K | 0.04% | 494 |
|
|
2019
Q2 | – | Sell |
-2,060
| Closed | -$187K | – | 1868 |
|
|
2019
Q1 | $187K | Buy |
2,060
+560
| +37% | +$50.8K | 0.03% | 497 |
|
|
2018
Q4 | $108K | Sell |
1,500
-560
| -27% | -$40.3K | 0.02% | 638 |
|
|
2018
Q3 | $197K | Buy |
2,060
+100
| +5% | +$9.56K | 0.03% | 505 |
|
|
2018
Q2 | $187K | Hold |
1,960
| – | – | 0.03% | 515 |
|
|
2018
Q1 | $172K | Buy |
1,960
+240
| +14% | +$21.1K | 0.03% | 529 |
|
|
2017
Q4 | $146K | Buy |
+1,720
| New | +$146K | 0.03% | 588 |
|